Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT01064401 · COMPLETED
Trial details
- NCT number
- NCT01064401
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2014-03-01
- Enrollment
- 1841
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.